Norio Akuta

21PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesHaematological tumoursPolitical economy and social changeCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 12, 2026
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.

|May 03, 2025
Peripheral blood CD4+/CD8+ T cell ratio may have potential for predicting the treatment response of durvalumab plus tremelimumab therapy (STRIDE) for unresectable hepatocellular carcinoma: Preliminary report.

Yusuke Kawamura, Norio Akuta, Junichi Shindoh

|Oct 29, 2024
Factors involved in gastroesophageal varix-related events in patients with hepatitis C virus-related compensated and decompensated cirrhosis after direct-acting antiviral therapy.

Yuki Tahata, Hayato Hikita, Satoshi Mochida

|Sep 26, 2024
Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapy.

Yusuke Kawamura, Norio Akuta, Junichi Shindoh

|Apr 19, 2024
Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021.

Hirayuki Enomoto, Norio Akuta, Hayato Hikita

|Dec 19, 2023
A new imaging classification for safer radial access visceral intervention of the liver and optimal case selection: A preliminary report.

Yusuke Kawamura, Norio Akuta, Shunichiro Fujiyama

Pageof 4

Frequent Collaborators

10 joint publications

Tetsuya Hosaka

10 joint publications

Yusuke Kawamura

4 joint publications

Shunichirou Fujiyama

3 joint publications

Hitomi Sezaki